Literature DB >> 10557076

Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.

H Xi1, D D Eason, D Ghosh, S Dovhey, K L Wright, G Blanck.   

Abstract

Class II transactivator (CIITA) activates the expression of major histocompatibility class II genes, which encode antigen-presenting molecules recognized by the T-cell receptor of CD4+ T cells. IFN-gamma induced CIITA transcription in many cell types is directed by the CIITA Type IV promoter. Here we report that the human CIITA Type IV promoter IRF-E binds IRF-1 and can be activated by exogenous expression of IRF-1. Surprisingly, the CIITA Type IV promoter IRF-E is also activated by IRF-2, another member of the IRF family that generally acts as a transcriptional repressor. In addition, we found that IRF-1 and IRF-2 synergistically activate the CIITA Type IV promoter. Electrophoretic mobility shift assays revealed that IRF-1 and IRF-2 can simultaneously occupy the IRF-E of the CIITA Type IV promoter, suggesting a novel mechanism for the role of these two proteins in promoter activation. Our results also indicate that IRF-1 and IRF-2 can cooperatively activate and co-occupy the IRF-E of the guanylate binding protein (GBP) promoter. Finally, CIITA induction by IFN-gamma does not occur in a pancreatic tumor cell line that expresses a mutated IRF-2, representing the first IRF-2 mutation identified in a human tumor cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557076     DOI: 10.1038/sj.onc.1202969

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.

Authors:  Lei Cui; Yuezhen Deng; Yefei Rong; Wenhui Lou; Zhengfa Mao; Yuanyuan Feng; Dong Xie; Dayong Jin
Journal:  Tumour Biol       Date:  2011-11-26

2.  Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.

Authors:  Janet F Piskurich; Carolyn A Gilbert; Brittany D Ashley; Mojun Zhao; Han Chen; Jian Wu; Sophia C Bolick; Kenneth L Wright
Journal:  Mol Immunol       Date:  2005-06-13       Impact factor: 4.407

3.  Cloning of an interferon regulatory factor 2 isoform with different regulatory ability.

Authors:  S A Koenig Merediz; M Schmidt; G J Hoppe; J Alfken; D Meraro; B Z Levi; A Neubauer; B Wittig
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.

Authors:  John M Yavorski; George Blanck
Journal:  Mol Clin Oncol       Date:  2017-09-29

5.  Mouse interferon regulatory factor-2: expression, purification and DNA binding activity.

Authors:  Krishna Prakash; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2011-05-11       Impact factor: 2.316

6.  Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.

Authors:  Han Chen; Carolyn A Gilbert; John A Hudson; Sophia C Bolick; Kenneth L Wright; Janet F Piskurich
Journal:  Mol Immunol       Date:  2006-06-12       Impact factor: 4.407

7.  Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.

Authors:  Samantha G Pattenden; Robert Klose; Elizabeth Karaskov; Rod Bremner
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

8.  MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.

Authors:  Mojun Zhao; Frederick L Flynt; Mei Hong; Han Chen; Carolyn A Gilbert; Nicole T Briley; Sophia C Bolick; Kenneth L Wright; Janet F Piskurich
Journal:  Mol Immunol       Date:  2007-02-14       Impact factor: 4.407

9.  Substantially reduced expression of PIAS1 is associated with colon cancer development.

Authors:  Domenico Coppola; Vevek Parikh; David Boulware; George Blanck
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-15       Impact factor: 4.553

10.  Identification of novel co-repressor molecules for Interferon Regulatory Factor-2.

Authors:  Kay S Childs; Stephen Goodbourn
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.